AI Writes Prescriptions: Healthcare's New Frontier?

Artificial intelligence is moving beyond administrative tasks to directly impact patient care, exemplified by Doctronic's pilot program in Utah, launched in December. This initiative is the first to utilize AI for generating prescription refills. The startup has secured $40 million in venture capital to further develop its AI clinical services.

Advocates believe AI can accelerate healthcare access and combat rising costs and physician shortages. Companies like Limbic are developing AI for mental health intake and therapy, with their AI platform, Limbic Access, holding regulatory approval in the UK. RecovryAI is creating virtual assistants for post-surgery recovery.

Doctronic's primary business involves video visits with human physicians, a service available nationwide. Their AI treatment plans have shown high affirmation rates from doctors in studies, though not yet peer-reviewed. The Utah pilot, operating under a regulatory sandbox, currently allows AI to refill 190 medications, with human doctors reviewing all prescriptions. Future phases may involve reduced human oversight, pending safety data. Medical associations, however, stress the necessity of physician oversight in prescription decisions, particularly concerning patient-specific risks.